AV名湿

CU Boulder researchers and inventors created a strong crop of 145 breakthrough technologies in 2022, with innovations in climate tech, biotechnology, quantum science, optics and aerospace, to name a few. Read more in Venture Partners at CU Boulder's 2022 Annual Report.

鈥淲e're looking for companies that have the most interesting, disruptive technology, that are managed and are founded by the strongest people ... [and] that are targeting products that really fit an unmet need in the market,鈥� said Mark Lupa, co-founder and general partner of Buff Gold Ventures.

The intermountain west innovation ecosystem came together at the fifth annual Destination Startup庐 showcase on Feb. 15 and 16, hosted by Venture Partners at CU Boulder. In a highly competitive field, 21 university ventures from intermountain west research institutions were selected to present at the showcase.

Solid Power鈥攁 CU Boulder spinout company that specializes in solid-state, sulfide-based electrolyte technology鈥攚ill develop a 3D-structured Li metal anode and novel sulfur composite cathode to enable high-energy and fast-charging EV battery cells. It hopes to scale so that energy-dense cell costs are reduced.

A CU Boulder startup that builds laser systems to monitor methane emissions, LongPath has received regulatory approval by the Colorado Department of Public Health & Environment and the U.S. Environmental Protection Agency鈥攖he first emissions-monitoring technology to be approved at both state and federal levels.

According to a new report from the Leeds School of Business, commercialization activities led by Venture Partners at CU Boulder had an economic impact of $8 billion nationally and $5.2 billion in the state of Colorado over the last five years鈥攁 four-fold increase in impact since 2019.

Twelve teams of University of Colorado faculty, researchers and graduate student innovators competed for a combined $1.25M in startup funding grants in this year鈥檚 Lab Venture Challenge. Judges from CU Boulder鈥檚 entrepreneurial network heard pitches in biosciences, physical sciences and engineering.

A global quantum ecosystem leader, ColdQuanta's product portfolio for commercialization includes quantum computing, quantum algorithms, atomic clocks, sensors and components鈥攁ll of which have a wide range of applications in communications, radio frequency (RF) technologies and more.

Arpeggio鈥檚 technology isolates a drug鈥檚 effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors. Funding was led by Builders VC and will support ongoing development of Arpeggio鈥檚 drug pipeline as well as its transcription-monitoring technologies.

The merger is addressing pressing needs in quantum research for CU Boulder spinout ColdQuanta鈥攁s well as the quantum industry. Both companies are affiliates of Q-NEXT, a U.S. Department of Energy (DOE) National Quantum Information Science AV名湿 Center led by Argonne National Laboratory.